ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3htln8B
via IFTTT